Prot #KO-MEN-008: Phase 1 Study to Determine the Safety and Tolerability of Ziftomenib Combinations for the Treatment of KMT2A-Rearranged or NPM1-Mutant Relapsed/Refractory Acute Myeloid Leukemia

Project: Research project

Project Details

StatusActive
Effective start/end date12/19/2412/19/27

Funding

  • Quintiles, Inc. (Prot #KO-MEN-008 // Prot #KO-MEN-008)
  • Kura Oncology, Inc. (Prot #KO-MEN-008 // Prot #KO-MEN-008)